Joseph F. Goldberg, MD

JCP
Educational Activity

July 6, 2021

Join Dr Goldberg as he reviews factors that impact the diagnosis of bipolar disorder and current treatments for bipolar depression in adults.
JCP
Letter to the Editor

June 22, 2021

Dr Goldberg responds to Dr Terao’s letter regarding a study of citalopram for bipolar depression.
JCP
Complex Polypharmacy in Bipolar Disorder
Insights

June 1, 2021

Which bipolar disorder patients are more likely to receive more than 2 medications, and why? In this video, Dr Goldberg discusses the findings of his recent systematic review focusing...
JCP
Systematic Review

June 1, 2021

Complex pharmacotherapy is common in patients with bipolar disorder. This study examined the prevalence of such complex regimens in bipolar disorder patients and sought to characterize factors that influence...
, ,
JCP
Preventing Functional Deterioration in Patients With Bipolar Disorder
Insights

April 15, 2021

Dr Joseph Goldberg and others explain why intervening early with effective treatment is critically important for preventing episodes and preserving functioning in patients with bipolar disorder.
, , , et al
JCP
Polypharmacy and the Concept of a “Foundational Treatment” for Bipolar Disorder
Insights

April 15, 2021

Learn how simplifying a bipolar disorder treatment regimen, with a single agent acting as the “foundation” and others added when needed, may both improve patient morale and be effective...
, , , et al
JCP
Progression of Symptoms Over the Course of Bipolar Disorder
Insights

April 13, 2021

Dr Joseph F. Goldberg discusses how symptoms and clinical presentation change over time in people with bipolar disorder, beginning from the prodromal phase
JCP
ASCP Corner

January 19, 2021

The question of whether, and when, antidepressants are appropriate in bipolar disorder is a hotly debated topic. This ASCP Corner article summarizes the key concepts with greatest relevance for...
, ,
JCP
Editorial

January 12, 2021

This editorial discusses a recent study of citalopram in bipolar depression and revisits the long-held assumption that antidepressants lead to poor outcomes in bipolar disorder.
JCP
Identifying Patients With Bipolar I Disorder Who Would Benefit From Maintenance Therapy With a Long-Acting Injectable Antipsychotic
Academic Highlights

June 16, 2020

In this article focusing on maintenance treatment of bipolar I disorder, experts discuss functional impairment, the potential for LAI antipsychotics to address nonadherence, and the characteristics of patients who...
, , , et al
JCP
Commentary

June 2, 2020

This commentary discusses the findings of a recent study by Maccariello et al on the prevalence and predictors of switch to depression in bipolar patients who recently initiated or...
JCP
Commentary

April 7, 2020

During the COVID-19 pandemic, psychiatrists may respond to the "all hands on deck" call from health care institutions. This commentary looks at how expertise in distinguishing and managing normal...

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe